BridgeMD
New treatment option for Depression
Official title Collaborative Stepped-care Intervention for Adults With Subthreshold Depressive Symptoms in the Primary Care Setting
ClinicalTrials.gov ID: NCT06658041
What this study is testing
- What it's testing
- To ensure accessibility and availability of mental health services in the community and to reduce the burden associated with depression and related conditions, the study aim to evaluate the effectiveness of a collaborative stepped-care intervention (cognitive behavioural therapy-based) for adults with subthreshold depressive symptoms at the district-based primary healthcare setting.
- Time commitment: about 3 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 59
You may be able to join if
- Residing in Hong Kong;
- Presenting mild to moderately severe depressive symptoms (PHQ-9 = 5-19);
- Able to give informed consent to participate.
You likely can't join if
- A known history of autism, intellectual disability, schizophrenia-spectrum disorder, bipolar disorder, Parkinson's disease, or dementia;
- Imminent suicidal risk;
- Difficulty in communication that would limit meaningful participation in psychological intervention.
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, HONG KONG, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 59 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, HONG KONG, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.